Merck KGaA banner

Merck KGaA
XMUN:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XMUN:MRK
Watchlist
Price: 141.95 EUR 5.54%
Market Cap: €18.3B

Wall St Price Targets

MRK Price Targets Summary
Merck KGaA

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 147.13 EUR with a low forecast of 119.86 EUR and a high forecast of 192.28 EUR.

Lowest Forecast
Price Target
119.86 EUR
16% Downside
Average Forecast
Price Target
147.13 EUR
4% Upside
Highest Forecast
Price Target
192.28 EUR
35% Upside
Merck KGaA Competitors:
Price Targets
PACB
Pacific Biosciences of California Inc
57% Upside
SVC
Service Properties Trust
40% Upside

Revenue
Forecast

5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.

Gross Profit
Forecast

4% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 3%.

Operating Income
Forecast

8% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

10% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 14%.

Net Income
Forecast

11% / Year
Past Growth
17% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
17% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MRK's stock price target?
Price Target
147.13 EUR

According to Wall Street analysts, the average 1-year price target for MRK is 147.13 EUR with a low forecast of 119.86 EUR and a high forecast of 192.28 EUR.

What is the Revenue forecast for Merck KGaA?
Projected CAGR
3%

Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.

What is the Gross Profit forecast for Merck KGaA?
Projected CAGR
3%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 3%.

What is the Operating Income forecast for Merck KGaA?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Merck KGaA?
Projected CAGR
14%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Merck KGaA?
Projected CAGR
17%

Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett